Latest Asx News

Chilwa Minerals confirmed a significant niobium discovery at its Nakombe target, progressing with dual diamond rig drilling and advancing a NASDAQ listing application. Heavy mineral sands resource work continues alongside a new ionic clay rare earth program.

Dimerix’s blinded review of its pivotal ACTION3 Phase 3 trial confirms over 90% statistical power to detect DMX-200’s effect on proteinuria, reinforcing the study’s design and regulatory pathway.

Centaurus Metals has secured a binding offtake deal with Glencore and attracted up to US$320 million in financing offers for its Jaguar Nickel Project, while advancing exploration and pilot testing at its Brazilian copper-gold and iron ore assets.

VBX Limited has more than doubled the Measured and Indicated Mineral Resource at its Wuudagu bauxite project to 131.9 million tonnes with improved grades, while also enhancing its Definitive Feasibility Study scope and securing additional funding.

Beach Energy’s Q3 FY26 output rose 7% quarter-on-quarter, led by a 174% surge in Perth Basin production following Waitsia Gas Plant compressor commissioning. The company also secured new Queensland acreage and greenlit the Moomba Central Optimisation project, though weather disruptions trimmed Cooper Basin output and prompted a production guidance cut.

AusQuest has confirmed a vast copper-gold system at its Cangallo project in Peru, revealing broad mineralisation and multiple higher-grade zones. Meanwhile, exploration momentum continues in Australia under a South32 alliance, with key drilling programs poised to start.

Biome Australia’s Activated Probiotics brand surpasses one million boxes sold in Australia, approaches top pharmacy ranking, and launches nationally in Canada, setting the stage for FY26 profitability.

1414 Degrees (ASX:14D) advances its SiNTL silicon anode technology, aiming to disrupt lithium-ion batteries in the rapidly expanding drone and UAV sector with higher capacity and faster charging.

Victory Metals has unlocked a rare metallurgical feat at North Stanmore, achieving a globally top-tier 72% heavy rare earth ratio and unveiling a second revenue stream from zircon-hafnium concentrate using a low-cost gravity separation process.

PYC Therapeutics fortified its balance sheet by $600 million and progressed key RNA therapeutic trials in Q1 2026, setting the stage for pivotal clinical data and regulatory submissions.

Pivotal Metals is progressing a mineral resource update and scoping study for its Horden Lake copper project in Québec, targeting a large open-pit operation with strong cashflow potential amid record copper prices.

Central Petroleum lifted March quarter sales revenue to $11.3 million, driven by higher gas volumes and prices, while securing a significant multi-year gas supply deal with the Northern Territory Government that supports a 40% production capacity increase at Palm Valley.